Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth-quarter 2025 investor letter.

AstraZeneca plans to delist from Nasdaq and move to the NYSE, while its breast cancer drug Enhertu enters European regulatory review after strong trial results.

Key Insights Using the 2 Stage Free Cash Flow to Equity, AstraZeneca fair value estimate is UK£250 AstraZeneca's ...

AstraZeneca's shares jumped after Pfizer's announcement of a major deal with the Trump administration. Pfizer's good news could benefit AstraZeneca, too. 10 stocks we like better than AstraZeneca Plc ...

The Nasdaq-100 Index is a globally recognized index that tracks the performance of 100 of the largest non-financial companies.

We recently published a list of 10 Best UK Stocks to Buy According to Billionaires. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best UK ...

AstraZeneca PLC ADR advanced stock charts by Barron's. View AZN historical stock data and compare to other stocks, and ...

We recently compiled a list of the Top 10 Oncology Stocks to Buy Now. AstraZeneca PLC is placed fourth on our list among the ...

The pharmaceutical sector mainstay reported good news about its developmental hypertension drug. It purchased the medicine's maker, CinCor Pharma, in early 2023. Early this morning, AstraZeneca shared ...

Walmart’s addition follows its move last year to shift its stock listing from the New York Stock Exchange to Nasdaq, the ...

or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...

AstraZeneca PLC AZN +2.41% shares advanced 2.41% to £143.46 Wednesday, on what proved to be an all-around positive trading ...